Our data seem to indicate that FISH-determined HER2 status but not p53 is associated with docetaxel sensitivity in metastatic breast cancer.
Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer / Camerini A; Donati S; Viacava P; Siclari O; Puccetti C; Tartarelli G; Valsuani C; De Luca F; Martini L; Cavazzana A; Amoroso D. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - ELETTRONICO. - (2011), pp. 30-38.
Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer
SICLARI, OLIMPIA;
2011
Abstract
Our data seem to indicate that FISH-determined HER2 status but not p53 is associated with docetaxel sensitivity in metastatic breast cancer.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
art%3A10.1186%2F1756-9966-30-38.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
2.75 MB
Formato
Adobe PDF
|
2.75 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
